Tripatide (Shenzhen Jianxiang Biological)

特立帕肽（深圳健翔生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTripatide (Shenzhen Jianxiang Biological)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShenzhen Jianxiang Biological Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Jianxiang Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoporosis, Postmenopausal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A